Provided by Tiger Trade Technology Pte. Ltd.

Coatue Management Holdings

4,263.10
-22.8525-0.53%
Number of Gainers:23
Number of Losers:38
Number of Flat:3
PE:- -
High:4,286.63
Open:4,285.78
Low:4,258.12
Close:4,285.61
Volume:125.12M
Turnover:14.88B
Market Cap:13.67T
Float Cap:12.57T

Loading ...

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

China Says Probe Targeted JD.com

THOMSON REUTERS
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Foresight Ventures VCT to Launch Streamlined Share Offer Under New Prospectus Rules

TIPRANKS
·
Aug 19

Nvidia (NVDA): New Buy Recommendation for This Technology Giant

TIPRANKS
·
Aug 19

Intuit : Deutsche Bank Cuts Target Price to $425 from $530

THOMSON REUTERS
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

AI Spending Just Revealed a $7,000 Gap Between Winners and Losers

InvestorPlace
·
Aug 19

META, MSFT and AMZN Face Rising Costs and Delays as AI Data Center Backlash Grows

TIPRANKS
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Analysts Offer Insights on Technology Companies: Broadcom (AVGO) and Cricut Inc (CRCT)

TIPRANKS
·
Aug 19

Analysts Offer Insights on Communication Services Companies: Roblox (RBLX) and AppLovin (APP)

TIPRANKS
·
Aug 19

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

TIPRANKS
·
Aug 19

Moderna Shares Extend Gains; Last up 46.9% Premarket

THOMSON REUTERS
·
Aug 19

Truist Raises Price Target on CrowdStrike Holdings to $245 From $188, Keeps Buy Rating

MT Newswires Live
·
Aug 19

AI and Robotics are a Battleground for U.S. and China. This is the Best Bet.

Dow Jones
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19